Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration (OSIVID)
Efficacy of Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration in Patients With Vitamin D Deficiency
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Alexandra Poinas, PhD
- Phone Number: 0253482857
- Email: alexandra.poinas@chu-nantes.fr
Study Contact Backup
- Name: Anne-Gaelle Chaux, MD PhD
- Phone Number: 02 53 48 28 35
- Email: annegaelle.chaux@chu-nantes.fr
Study Locations
-
-
Nantes
-
Nantes, Nantes, France, 44000
- Recruiting
- CHU Nantes-Department of Dentistry
-
Contact:
- Alexandra Poinas
- Phone Number: +33 2 40 08 33 33
- Email: alexandra.poinas@chu-nantes.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female patient ≥ 18 years old, candidate for dental implant placement.
- with vitamin D deficiency or insufficiency: 25(OH)D < 25 ng/L.
- affiliated with a social security scheme.
Exclusion Criteria:
- with a local contraindication for implant placement.
- under guardianship, curatorship, or legal protection
- Pregnant or breastfeeding women
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
patient with supplementation of vitamin D3
perioperative oral vitamin D3 supplementation on implant osseointegration in patients with vitamin D deficiency.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The stability of the implan
Time Frame: 3 months (surgery and 3 months after)
|
The stability of the implant measured by RFA (Resonance Frequency Analysis)
|
3 months (surgery and 3 months after)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Anne-Gaelle Chaux, MD PhD, Nantes university hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- AP_AGC_osivid_001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.